US Broker Ratings

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 27.82% Upside Potential

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, is drawing significant attention from investors, thanks to its strong growth metrics and..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Insights into a Biotech Powerhouse with 100% Revenue Growth

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has been making waves with its impressive 100.70% revenue growth, capturing the attention of..

Alkermes plc (ALKS) Stock Analysis: Discovering a 46.76% Upside Potential in the Biopharma Space

Investors seeking opportunities in the healthcare sector might find Alkermes plc (NASDAQ: ALKS) an intriguing prospect given its significant upside potential. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Giant with a 6.39% Potential Upside

Doximity, Inc. (NASDAQ: DOCS) is a formidable player in the healthcare technology space, providing an essential digital platform tailored for medical professionals. Headquartered in San Francisco,..

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 25% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors in the healthcare sector, thanks to its strong growth metrics and favorable analyst ratings...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Assessing a 48% Potential Upside Opportunity

Lantheus Holdings, Inc. (NASDAQ: LNTH), a significant player in the healthcare sector specializing in the development and commercialization of diagnostic and therapeutic products, is capturing investor..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader with Strong Revenue Growth and Analyst Support

Investors with a keen eye on the healthcare sector should take a closer look at The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Biotech Giant with 10% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) has emerged as a key player in the biotechnology sector, offering a unique investment opportunity with its robust pipeline and strategic..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 9% Potential Downside Amidst Steady Growth

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specializes in medical devices with a focus on life science research and clinical diagnostics...

Bio-Techne Corp (TECH) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Ratings

Bio-Techne Corporation (NASDAQ: TECH) stands as an intriguing player in the biotechnology sector, drawing investor interest due to its robust market presence and strategic positioning in..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 26.99% Upside Potential in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) is garnering significant attention from investors in the biotechnology sector. As a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, Nuvalent is dedicated..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and Promising 8.68% Upside

Exact Sciences Corporation (NASDAQ: EXAS) has established itself as a significant player in the healthcare sector, specifically within the diagnostics and research industry. The company’s innovative..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: 74% Potential Upside Ignites Investor Interest

For investors seeking opportunities in the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents a compelling case. With a market capitalization of $10.46 billion, this San..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring 9.59% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NASDAQ: STVN), a notable player in the healthcare sector, has been gaining traction among investors with its robust portfolio of medical instruments and..

Humana Inc. (HUM) Stock Analysis: Navigating Growth in the Healthcare Plans Sector

As an integral player in the healthcare plans industry, Humana Inc. (NYSE: HUM) continues to captivate investor interest with its expansive portfolio and strategic positioning in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Capitalizing on a 14.39% Potential Upside

Investors eyeing the healthcare sector may want to keep a close watch on Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company renowned for its innovative enzyme..

Legend Biotech Corporation (LEGN) Stock Analysis: A 135% Upside Potential in Revolutionary Cancer Therapies

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its remarkable potential in the biotechnology sector, particularly in the realm of oncology treatments...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating the Highs with a 73.7% Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, is capturing the attention of investors with its impressive financial metrics and strategic positioning..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Frontier with a Market Cap of $15.5 Billion

Tempus AI, Inc. (NASDAQ: TEM) is carving a niche in the healthcare technology sector, with its innovative approach to health information services. The company, headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds